New Hepatitis C antiviral drug provided cure to more than 90% of patients in clinical trail study. After decades of identifying liver causing disease virus Hep. C, new drug is a light at the end of the tunnel for patients that have failed to clear virus. Regiment of 12 weeks with FDA approved sofosbuvir cocktail proven effective in most stubborn genotype 1a infection with little side-effect comparing to previous drug cocktail  treatments. The cost of new HCV treatment comes with steep price tag of $84000.00 or $1000.00 per tablet which most patients can not afford, while health insurance industry in US will most likely only pay for patients with high risk of developing liver cancer or liver cirrhosis.                                                                                                                                                                      There is also possibility that same medication developed by Gilead Sciences & AbbVie of Chicago will be available to other countries for much less on price tag.

Initiated research phase 2 study announced on Apr. 1st.  2014 by chief executive officer of  Achillion pharmaceuticals, to evaluate the safety, tolerability and antiviral activity of second generation  inhibitor, with sofosbuvir for 8 weeks of treatment or less in genotype 1 to clear HCV.  Study results will be available end of this year.

This entry was posted in News. Bookmark the permalink.

One Response to HEPATITIS C CURE

  1. Pingback: Online CPR Certification Courses & Classes ...

Leave a Reply